Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-1.9%
5Y CAGR+56.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-1.9%/yr
vs +115.7%/yr prior
5Y CAGR
+56.6%/yr
Recent deceleration
Acceleration
-117.7pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
9.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $22.93M | -25.6% |
| 2024 | $30.80M | -22.0% |
| 2023 | $39.50M | +62.5% |
| 2022 | $24.31M | +140.6% |
| 2021 | $10.10M | +315.0% |
| 2020 | $2.43M | +546.0% |
| 2019 | $376860.00 | -66.4% |
| 2018 | $1.12M | - |